Characterization of recombinant influenza A virus as a vector expressing respiratory syncytial virus fusion protein epitopes

Journal of General Virology

Volumn 95, Issue PART 9, 2014, Pages 1886-1891

  Zhang, Peirui ^a   Gu, Hongjing ^b   Bian, Chengrong ^a   Liu, Na ^b,c   Li, Zhiwei ^a   Duan, Yueqiang ^b   Zhang, Shaogeng ^a   Wang, Xiliang ^b   Yang, Penghui ^a,b  

^a 302 MILITARY HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NONSTRUCTURAL PROTEIN 1; RECOMBINANT INFLUENZA VIRUS RESPIRATORY SYNCYTIAL VIRUS F PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS VECTOR;

ADENOCARCINOMA CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; GENE INSERTION; GENE PRODUCT; HEMAGGLUTINATION INHIBITION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IN VIVO STUDY; INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); LIPID BILAYER; LUNG ADENOCARCINOMA; MDCK CELL LINE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE GENETICS; TH1 CELL; VIRUS CHARACTERIZATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS REPLICATION; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; COS CELLS; DOGS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL FUSION PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84906269072     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.064105-0     Document Type: Article

References (27)

1. Chen, Z., Wang, W., Zhou, H., Suguitan, A. L., Jr, Shambaugh, C., Kim, L., Zhao, J., Kemble, G. & Jin, H. (2010). Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84, 44-51.
2. Collins, P. L. & Melero, J. A. (2011). Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 162, 80-99.
3. De Baets, S., Schepens, B., Sedeyn, K., Schotsaert, M., Roose, K., Bogaert, P., Fiers, W. & Saelens, X. (2013). Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice. J Virol 87, 3314-3323.
4. de Goede, A. L., Boers, P. H., Dekker, L. J., Osterhaus, A. D., Gruters, R. A. & Rimmelzwaan, G. F. (2009). Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag. Vaccine 27, 5735-5739.
5. Fuller, H. & Del Mar, C. (2006). Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev (4), CD004883.
6. Fuller, H. L. & Del Mar, C. B. (2010). WITHDRAWN: immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev (9), CD004883.
7. He, Q., Martinez-Sobrido, L., Eko, F. O., Palese, P., Garcia-Sastre, A., Lyn, D., Okenu, D., Bandea, C., Ananaba, G. A. & other authors (2007). Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology 122, 28-37.
8. Hoffmann, E., Stech, J., Guan, Y., Webster, R. G. & Perez, D. R. (2001). Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146, 2275-2289.
9. Horimoto, T., Iwatsuki-Horimoto, K., Hatta, M. & Kawaoka, Y. (2004). Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components. Microbes Infect 6, 579-583.
10. Jones, B. G., Sealy, R. E., Rudraraju, R., Traina-Dorge, V. L., Finneyfrock, B., Cook, A., Takimoto, T., Portner, A. & Hurwitz, J. L. (2012). Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine 30, 959-968.
11. Kamphuis, T., Meijerhof, T., Stegmann, T., Lederhofer, J., Wilschut, J. & de Haan, A. (2012). Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice. PLoS ONE 7, e36812.
12. Kittel, C., Sereinig, S., Ferko, B., Stasakova, J., Romanova, J., Wolkerstorfer, A., Katinger, H. & Egorov, A. (2004). Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 324, 67-73.
13. Kittel, C., Ferko, B., Kurz, M., Voglauer, R., Sereinig, S., Romanova, J., Stiegler, G., Katinger, H. & Egorov, A. (2005). Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J Virol 79, 10672-10677.
14. Li, Z. N., Mueller, S. N., Ye, L., Bu, Z., Yang, C., Ahmed, R. & Steinhauer, D. A. (2005). Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity. J Virol 79, 10003-10012.
15. + responses in mice. Proc Natl Acad Sci U S A 95, 3954-3959.
16. Neumann, G. & Kawaoka, Y. (2001). Reverse genetics of influenza virus. Virology 287, 243-250.
17. Oshansky, C. M., Zhang, W., Moore, E. & Tripp, R. A. (2009). The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol 4, 279-297.
18. Percy, N., Barclay, W. S., García-Sastre, A. & Palese, P. (1994). Expression of a foreign protein by influenza A virus. J Virol 68, 4486-4492.
19. Robinson, K. A., Odelola, O. A., Saldanha, I. J. & McKoy, N. A. (2012). Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Database Syst Rev 2, CD007743.
20. Sawada, A., Komase, K. & Nakayama, T. (2011). AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats. Vaccine 29, 1481-1490.
21. Schmidt, M. R., McGinnes, L. W., Kenward, S. A., Willems, K. N., Woodland, R. T. & Morrison, T. G. (2012). Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol 86, 11654-11662.
22. + Th1 immune response and protect animals against tuberculosis challenge. Clin Vaccine Immunol 13, 898-904.
23. Singh, S. R., Dennis, V. A., Carter, C. L., Pillai, S. R. & Moore, E. G. (2007). Respiratory syncytial virus recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice. Viral Immunol 20, 261-275.
24. Strobel, I., Krumbholz, M., Menke, A., Hoffmann, E., Dunbar, P. R., Bender, A., Hobom, G., Steinkasserer, A., Schuler, G. & Grassmann, R. (2000). Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector. Hum Gene Ther 11, 2207-2218.
25. Stukova, M. A., Sereinig, S., Zabolotnyh, N. V., Ferko, B., Kittel, C., Romanova, J., Vinogradova, T. I., Katinger, H., Kiselev, O. I. & Egorov, A. (2006). Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) 86, 236-246.
26. Webster, R. G., Kawaoka, Y., Taylor, J., Weinberg, R. & Paoletti, E. (1991). Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9, 303-308.
27. Yang, P., Duan, Y., Wang, C., Xing, L., Gao, X., Tang, C., Luo, D., Zhao, Z., Jia, W. & other authors (2011). Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. Vaccine 29, 698-705.